Hand clinical trials

Explore recruiting hand clinical trials.

Recruiting hand studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hand trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A phase 3b, interventional, adaptive, clinical trial to evaluate the efficacy and safety of tralokinumab 300 mg every second week monotherapy compared with placebo in subjects with moderate-to-severe atopic hand eczema who are candidates for systemic therapy (ADHAND)

Sweden, France, Czechia, Germany, Portugal, Belgium +3 more

Phase III and phase IV (Integrated) EU CTIS Study details

AliCsa; Efficacy of oral alitretinoin versus oral cyclosporine in patients with moderate to very severe hand eczema. A randomized prospective open-label trial with blinded outcome assessment

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Exploratory Study of CAPEcitabine pharmacokinetics and hand-foot syndrome in CES1 variant carriers: the ESCAPE study

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Towards a treatment for accelerated maturation in girls testing spiomet in a randomised placebo controlled, multicentre study.

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

The Methotrexate in ERosive INflammatory Osteoarthritis (MERINO) trial: A randomized placebo-controlled trial to investigate clinical efficacy and safety of methotrexate in erosive inflammatory hand osteoarthritis

Norway

Therapeutic use (Phase IV) EU CTIS Study details

The efficacy and safety of Intramuscular Methylprednisolone in patients with Hand OsteoArthritis: the IMHOA trial

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Hand trials by city

Hand in Toronto Hand in Vancouver Hand in Montreal Hand in Calgary Hand in Edmonton Hand in Ottawa Hand in Winnipeg Hand in Quebec City Hand in Hamilton Hand in Kitchener Hand in London Hand in Halifax Hand in New York Hand in Los Angeles Hand in Chicago Hand in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease